FDAnews
www.fdanews.com/articles/96964-dade-behring-siemens-deal-unlikely-to-raise-major-competition-issues-but-phase-ii-cannot-be-excluded

Dade Behring/Siemens Deal Unlikely to Raise Major Competition Issues But Phase II Cannot Be Excluded

August 8, 2007

Siemens’ acquisition of Illinois-based diagnostics company Dade Behring is unlikely to raise major competition issues but in-depth investigations cannot be excluded, according to sources and observers.
FT.com